, La prothèse amovible était une solution prothétique présente chez quatre participants, chacun avaient une prothèse amovible maxillaire et trois avaient aussi une prothèse amovible mandibulaire. Le seul patient édenté bi-maxillaire de notre étude ne possédait pas de prothèse amovible
, Deux prothèses complètes (n=2, 50%) -Une prothèse amovible partielle résine (n=1, 25%) -Une prothèse partielle métallique (n=1, 25%)
, La prothèse maxillaire était portée chez 75% des patients (n=3) alors que la moitié des prothèses avait des défauts d'intégrité (n=2, 50%), de rétention (n=2, 50%)
, Prothèses amovibles mandibulaires Trois patients présentaient une prothèse amovible mandibulaire : -Deux prothèses amovibles partielles métalliques (n=2, 66,7%) -Une prothèse amovible partielle résine (n=1, vol.3, p.33
, Aucune prothèse ne présentait de l'usure ou un manque d'intégrité, Les prothèses étaient portées dans les deux tiers des cas (n=2, 66,7%)
, Dix-huit patients avaient un édentement non compensé à la mandibule
, De la plaque était présente en excès dans la plupart des prothèses amovible maxillaires (75%) et mandibulaires (66,7%) (Tableau n°26)
, La moitié des détenteurs de prothèses amovibles ne les nettoyait jamais (n=2, 50%). L'autre moitié affirmait nettoyer leurs prothèses « plusieurs fois par semaine » (n=1, 25%)
Constitution de l'organisation mondiale de la santé, vol.1, pp.1-18, 1946. ,
, Troubles mentaux et du comportement, Aide Mémoire Rapp Sur Santé Dans Monde, pp.1-4, 2001.
Feuille de route : Santé mental et psychiatrie, pp.1-31, 2018. ,
, Améliorer la qualité du système de santé et maitriser les dépenses : propositions de l'assurance maladie pour 2020, pp.8-260, 2019.
, , 2019.
,
, Inserm -La science pour la santé, 2019.
,
L'état de santé de la population en France : Rapport, pp.260-91, 2017. ,
The World Oral Health Report 2003 = Continuous improvement of oral health in the 21st century -the approach of the WHO Global Oral Health Programme, pp.1-34, 2003. ,
Prévention bucco-dentaire en psychiatrie, Santé Ment, pp.41-45, 2017. ,
Oral health impacts of medications used to treat mental illness, J Affect Disord, vol.233, pp.184-93, 2017. ,
, American Psychiatric Association. Manuel diagnostique et statistique des troubles mentaux. 5 e éd, 2015.
Épidémiologie des troubles schizophréniques, Presse Médicale, vol.35, issue.3, pp.461-469, 2006. ,
Prévalence de la schizophrénie et autres troubles psychotiques en France métropolitaine, National Health Service. Schizophrenia, vol.29, issue.8, 2014. ,
Advancing Paternal Age and Schizophrenia: The Impact of Delayed Fatherhood, Schizophr Bull, vol.41, issue.3, pp.708-722, 2015. ,
Paternal Age and Risk of Schizophrenia in Adult Offspring, Am J Psychiatry, vol.159, issue.9, pp.1528-1561, 2002. ,
Maternal Bacterial Infection During Pregnancy and Offspring Risk of Psychotic Disorders: Variation by Severity of Infection and Offspring Sex, Am J Psychiatry, pp.1-10, 2019. ,
Meta-analysis of the association of urbanicity with schizophrenia, Schizophr Bull, vol.38, issue.6, pp.1118-1141, 2012. ,
Schizophrenia in mid-adulthood after prenatal exposure to the Chinese : Famine of 1959-1961, Schizophr Res, vol.184, pp.21-26, 2017. ,
Birth seasonality in schizophrenia: effects of gender and income status, Psychiatry Clin Neurosci, vol.67, issue.6, pp.426-459, 2013. ,
The association between season of birth, age at onset, and clozapine use in schizophrenia, Acta Psychiatr Scand, vol.136, issue.5, pp.445-54, 2017. ,
Season of birth and schizophrenia: Evidence from China, Psychiatry Res, vol.253, issue.1, pp.189-96, 2017. ,
Glycemia and Antipsychotic Medications: An Expert Consensus Review, Can J Diabetes, vol.29, issue.2, pp.113-134, 2005. ,
Prevalence of suicide attempts in individuals with schizophrenia: a meta-analysis of observational studies, Epidemiol Psychiatr Sci, pp.1-10, 2019. ,
Increased schizophrenia family history burden and reduced premorbid IQ in treatment-resistant schizophrenia: a Swedish National Register and Genomic Study, Mol Psychiatry, pp.1-9, 2019. ,
Incidence of cancer among persons with schizophrenia and their relatives, Arch Gen Psychiatry, vol.58, issue.6, pp.573-581, 2001. ,
, Les médicaments de la schizophrénie -EurekaSanté par VIDAL
, , 2019.
Severe and Uncommon Involuntary Movement Disorder due to Psychotropic Drugs ,
, PharmacoPsychiatry, vol.37, issue.1, pp.54-64, 2004.
Active monitoring of 12760 clozapine recipients in the UK and Ireland, Br J Psychiatry, vol.175, issue.6, pp.576-80, 1999. ,
What we know and what we don't know about the treatment of schizoaffective disorder, Eur Neuropsychopharmacol, vol.21, issue.9, pp.680-90, 2011. ,
Lifetime Prevalence of Psychotic and Bipolar Disorders in a General Population, Arch Gen Psychiatry, vol.64, issue.1, pp.19-28, 2007. ,
Family History of Psychiatric Illness as a Risk Factor for Schizoaffective Disorders : A Danish Register-Based Cohort Study, Arch Gen Psychiatry, vol.62, issue.8, pp.841-849, 2005. ,
,
, Hyperprolinemia is a risk factor for schizoaffective disorder, Mol Psychiatry, vol.10, issue.5, pp.479-85, 2005.
Cannabis use and depression: a longitudinal study of a national cohort of Swedish conscripts, BMC Psychiatry, vol.12, issue.112, pp.1-7, 2012. ,
Life events in schizoaffective disorder: a systematic review, J Affect Disord, vol.227, pp.563-70, 2018. ,
Symptoms, subtype, and suicidality in patients with schizophrenia spectrum disorders, Am J Psychiatry, vol.154, issue.2, pp.199-204, 1997. ,
Treatment of Schizoaffective Disorder, Psychiatry Edgemont, vol.6, issue.3, pp.15-22, 2009. ,
Rapport d'activité, 2018. ,
Oral health in schizophrenia patients: A French Multicenter Cross-Sectional Study, Presse Médicale, vol.48, issue.2, pp.89-99, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02152879
Prevalence of obesity and diabetes in patients with schizophrenia, World J Diabetes, vol.8, issue.8, pp.390-396, 2017. ,
Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional study, Clin Pract Epidemiol Ment Health, vol.27, issue.2, p.14, 2006. ,
Lifestyle and physical health in schizophrenia, Adv Psychiatr Treat, vol.11, issue.2, pp.125-157, 2005. ,
Almost All Antipsychotics Result in Weight Gain: A Meta-Analysis, Plos One, vol.9, issue.4, pp.1-19, 2014. ,
,
, Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls, World Psychiatry, vol.16, issue.2, pp.163-80, 2017.
Metabolic syndrome in people with schizophrenia: a review, World Psychiatry, vol.8, issue.1, pp.15-22, 2009. ,
Temporal trends in cardiovascular disease risk factor profiles in a population-based scizophrenia sample: a repeat cross-sectional study, J Epidemiol Community Health, vol.72, issue.1, pp.71-78, 2018. ,
Effects of cannabis smoking on oral soft tissues, Community Dent Oral Epidemiol, vol.21, issue.2, pp.78-81, 1993. ,
Cannabis and caries -Does regular cannabis use increase the risk of caries in cigarette smokers, Schweiz Monatsschr Zahnmed, vol.119, issue.6, pp.576-83, 2009. ,
Cannabis smoking and periodontal disease among young adults, J Am Med Assoc, vol.299, issue.5, pp.525-556, 2008. ,
The psychopathology medical management and dental implications of schizophrenia, J Am Dent Assoc, vol.133, issue.5, pp.603-613, 2002. ,
Evaluation de l'influence des psychotropes sur la santé bucco-dentaire chez une population de patients hospitalisés en secteur psychiatrique, Inf Dent, vol.88, issue.9, pp.439-480, 2006. ,
Tobacco use and oral disease, J Dent Educ, vol.65, issue.4, pp.306-316, 2001. ,
Prevalence of alcohol use disorders in schizophrenia -a systematic review and meta-analysis, Acta Psychiatr Scand, vol.120, issue.2, pp.85-96, 2009. ,
Alcohol and mouth cancer, Br Dent J, vol.225, issue.9, pp.880-883, 2008. ,
Alcohol consumption and site-specific cancer risk: a comprehensive dose-response meta-analysis, Br J Cancer, vol.112, issue.3, pp.580-93, 2015. ,
Oral Health status of psychiatric in patients in serbia and implications for their dental care, Croat Med J, vol.51, issue.5, pp.443-50, 2010. ,
Dental caries status of patients with schizophrenia in seville, Spain : a casecontrol study, BMC Res Notes, vol.10, issue.50, p.50, 2017. ,
Effectiveness of oral health education on oral hygiene status among schizophrenic patients : A randomized controlled study. Spec Care Dent, vol.39, pp.1-7, 2019. ,
Oral Hygiene -A Challenge in Everyday Life for people with schizophrénia, Issues Ment Health Nurs, vol.38, issue.8, pp.1-7, 2017. ,
Oral health status of elderly hospitalised psychiatric patients, Gerodontology, vol.29, issue.4, pp.272-83, 2012. ,
Signs of bruxism and temporomandibular disorders among psychiatric patients. Oral Surg Oral Med Oral Pathol Oral Radiol, vol.103, pp.60-63, 2007. ,
Temporomandubular disorders in patients with schizophrenia using antipsychotic agents. Drug Health Care Patients Saf, vol.10, pp.21-28, 2014. ,
Orofacial movement disorders, Oral Maxillofac Surg Clin N Am, vol.20, issue.2, pp.273-85, 2008. ,
Temporomandibular disorders among schizophrenic patients : a case-control study, Med Oral Patol Oral Cir Bucal, vol.10, issue.4, pp.315-337, 2005. ,
Prevalence of temporomandibular disorder signs in patients with schizophrenia, J Oral Rehabil, vol.36, issue.12, pp.864-71, 2009. ,
Assessment of oral mucosal lesions among psychiatric inmates residing in central jail, Indian J Psychiatry, vol.56, issue.3, pp.265-70, 2014. ,
An assessment of the dental health of chronic institutionalized patients withpsychiatric disease in Israel. Spec Care Dent, vol.30, pp.18-22, 2010. ,
Consensus report : chronic periodontititis, Ann Periodontol, vol.4, issue.1, p.38, 1999. ,
An assessment of periodontal health in patients with schizophrenia and taking antipsychotic medication, Int J Dent Hyg, vol.11, issue.2, pp.78-83, 2013. ,
The oral health of people with chronic schizophrenia: A neglected public health burden, Aust New Zeland J Psychiatry, vol.50, issue.7, pp.685-94, 2015. ,
,
, , 2018.
,
Periodontal Disease : The sixth complication of diabetes mellitus, Diabetes Care, vol.16, issue.1, pp.329-363, 1993. ,
Type 2 diabetes mellitus and periodontal disease, J Am Dent Assoc, vol.121, issue.4, pp.532-538, 1990. ,
Periodontal predicaments and associated risk factors among patients with schizophrenia, Neurol Psychiatry Brain Res, vol.32, pp.36-41, 2019. ,
Dental plaque as a biofilm and a microbial community -implications for health and disease, BMC Oral Health, vol.6, issue.1, p.14, 2006. ,
Titratable acidity of beverages influences salivary pH recovery, Braz Oral Res, vol.29, issue.32, p.1, 2015. ,
Dietary patterns and physical activity in people with schizophrenia and increased waist circumference, Schizophr Res, vol.199, pp.109-124, 2018. ,
Is dietary pattern of schizophrenia patients different from healthy subjects ? BMC Psychiatry, vol.7, pp.1-5, 2007. ,
Oral health status and treatment needs in institutionalized psychiatric patients : one year descriptive cross sectional study, Indian J Dent Res, vol.17, issue.4, pp.171-178, 2006. ,
Prévalence of dental caries in hospitalized patients with schizophrenia, Vojnosanit Pregl, vol.73, issue.12, pp.1102-1110, 2016. ,
Poor oral health in patients with schizophrenia: A systematic review and meta-analysis, Schizophr Res, vol.201, pp.3-9, 2018. ,
Advanced dental disease in people withsevere mental illness: systematic reviewand meta-analysis, Br J Psychiatry, vol.199, issue.3, pp.187-93, 2011. ,
Oral health status and treatment needs among psychiatric inpatients in Rennes, France: a Cross-sectional study, BMC Psychiatry, vol.13, issue.227, pp.1-9, 2013. ,
The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia, Schizophr Bull, vol.13, issue.2, pp.261-76, 1987. ,
Perez-Ansorena M. Oral health and the symptoms of schizophrenia, Psychiatry Res, vol.188, issue.1, pp.24-32, 2011. ,
Saliva secretion disorder in a schizophrenic patient a problem in dental and psychiatric treatment a case report, Ann Gen Psychiatry, vol.14, issue.14, pp.1-5, 2015. ,
Effects of antipsychotic polypharmacy on side effects and concurrent use of medications in schizophrenic outpatients, Psychiatry Clin Neurosci, vol.66, issue.5, pp.405-415, 2012. ,
The oral health of long-term psychiatric inpatients in Singapore, Psychiatry Res, vol.266, pp.206-217, 2018. ,
Drug effects on salivary glands : dry mouth, Oral Dis, vol.9, issue.4, pp.165-76, 2003. ,
Relationship between xerostomia and psychotropic drugs in patients with schizophrenia : evaluation using an oral moisture meter, J Clin Pharm Ther, vol.41, issue.6, pp.684-692, 2016. ,
Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy, Arch Gen Psychiatry, vol.59, issue.1, pp.62-71, 2002. ,
Severity of illness and extra pyramidal symptoms as predictors for oral diseases among patients with schizophrenia, Acta Odontol Scand, vol.75, issue.3, pp.220-226, 2017. ,
Comparative risk of oral ulcerations among antipsychotics users -population-based retrospective cohort study, Pharmacoepidemiol Drug Saf, vol.25, issue.2, pp.123-155, 2016. ,
Dental Health and the Type of Antipsychotic Treatment in Inpatients with Schizophrenia, Isr J Psychiatry Relat Sci, vol.52, issue.2, pp.114-88, 2015. ,
The Course of Myalgia and Headache After Electroconvulsive Therapy, J ECT, vol.26, issue.2, pp.116-136, 2010. ,
Adverse Effects of Electroconvulsive Therapy, Psychiatr Clin North Am, vol.39, issue.3, pp.513-543, 2016. ,
Oral Health in Electroconvulsive Therapy :A Neglected Topic, J ECT, vol.33, issue.1, pp.12-17, 2017. ,
Dental prosthetic treatment needs of inpatientswith schizophrenia in Taiwan: a cross-sectional study, BMC Oral Health, 2013. ,
Oral health of patients on psychotropic medications: a study of outpatients in Queensland, Australas Psychiatry, vol.21, issue.4, pp.338-380, 2013. ,
Oral health of psychiatric inpatients: a survey of central Taiwan hospitals, Gen Hosp Psychiatry, vol.33, issue.3, pp.253-262, 2011. ,
Barriers to special care patients with mental illness receiving oral healthcare : A cross sectional study in the Holy City of Makkah, Saudi Arabia, Saudi Med J, vol.39, issue.4, pp.419-442, 2018. ,
Actes et préstations longue durée: Schizophrénies. Serv Affect Longue Durée Accords Conv, pp.1-13, 2017. ,
, Service médicale de l'assurance maladie. Exonération du ticket modérateur en rapport avec une Affection de Longue Durée et odontologie
, Direction Régionale du Service médical PACA Corse, 2015.
The dental health of people with schizophrenia, Acta Psychiatr Scand, vol.110, issue.4, pp.306-316, 2004. ,
Studies on Dental Caries. I. Dental Status and Dental Needs of Elementary School Children, Public Health Rep, vol.53, pp.751-65, 1938. ,
Studies on dental caries : Sex differences in dental caries experience of elementary school children, Public Health Rep, vol.53, issue.38, pp.1685-90, 1938. ,
Dental Caries in American Indian Children, Public Health Bull, issue.239, pp.1-54, 1937. ,
The simplified oral hygiene index, J Am Dent Assoc, vol.68, issue.1, pp.7-13, 1964. ,
, Simplified Oral Hygiene Index | OHI-S -Malmö University
, Oral-Hygiene-Indices/Simplified-Oral-Hygiene-Index
The Xerostomia inventory: a multi-item approach to measuring dry mouth, Community Dent Health, vol.16, pp.12-19, 1999. ,
Shortening the Xerostomia Inventory. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, vol.112, pp.322-329, 2011. ,
Validity of three screening questions (3Q/TMD) in relation to the DC/TMD, J Oral Rehabil, vol.43, issue.10, pp.729-765, 2016. ,
Arrêté du 20 août 2018 portant approbation de la convention nationale organisant les rapports entre les chirurgiens-dentistes libéraux et l'assurance maladie ,
Texte 5 sur 147, SSAS1821640A Aout, 2018. ,
Décret n° 2017-708 du 2 mai 2017 modifiant le référentiel d'accès à la prestation de compensation fixé à l'annexe 2-5 du code de l'action sociale et des familles, 2017. ,
The effect of dietary and physical activity pattern on metabolic profile in individuals with schizophrenia: A crosssectional study, Compr Psychiatry, vol.53, issue.7, pp.1028-1061, 2012. ,
Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review, BMC Geriatr, vol.15, issue.31, pp.1-14, 2015. ,
Vandel Stichele R. Systematic review of anticholinergic risk scales in older adults, Eur J Clin Pharmacol, vol.69, issue.7, pp.1485-96, 2013. ,
Psychometric characteristics of the "General Oral Health Assessment Index (GOHAI) » in a French representative sample of patients with schizophrenia, BMC Oral Health, vol.17, issue.1, p.75, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01670772
Validation of an oral health quality of life index (GOHAI) in France, Community Dent Oral Epidemiol, vol.31, pp.275-84, 2003. ,
Development of the Geriatric Oral Health Assessment Index, J Dent Educ, vol.54, issue.11, pp.680-687, 1990. ,
The use of dental anxiety questionnaires: a survey of a group of UK dental practitioners, Br Dent J, vol.190, issue.8, pp.450-453, 2001. ,
Does completing a dental anxiety questionnaire increase anxiety? A randomised controlled trial with adults in general dental practice, Br Dent J, vol.201, issue.1, pp.33-38, 2006. ,
Factors which influence the oral condition of chronic schizophrenia patients. Spec Care Dent, vol.16, pp.84-90, 1996. ,
A comparison of the dental status and treatment needs of older adults with and without chronic m ental illness in Sevilla, Spain. Med Oral Patol Oral Cirugia Bucal, vol.18, pp.71-76, 2013. ,
The oral health of psychiatric in-patients in South Wales. Spec Care Dent, vol.21, pp.182-188, 2001. ,
Dental health and treatment needs in institutionalized psychiatric patients in Italy, Community Dent Oral Epidemiol, vol.23, issue.6, pp.360-364, 1995. ,
Oral Health Status and Oral Health-Related Quality of Life in Italian Deinstitutionalized Psychiatric Patients, Clin Ther, vol.168, issue.2, pp.77-83, 2017. ,
Comparison of oral health between inpatients with schizophrenia and disabled people or the general population, J Formos Med Assoc, vol.111, issue.4, pp.214-223, 2012. ,
, Agriculture Organization of the United Nations. Sugar. OECD-FAO Agric, pp.139-276, 2018.
Guidelines : Sugar intake for adults and children, pp.1-59, 2015. ,
Dental conditions in inpatients with schizophrenia: A large-scale multi-site survey, BMC Oral Health, vol.12, issue.32, pp.1-6, 2012. ,
The relationship between body ass index, the use of second-generation antipsychotics, and dental caries among hospitalized patients with schizophrenia, Int J Psychiatry Med, vol.41, issue.4, pp.343-53, 2011. ,
Decreased pain sensitivity among people with schizophrenia: a meta-analysis of experimental pain induction studies, Pain, vol.156, issue.11, pp.2121-2152, 2015. ,
Commission de la transparence : avis : clozapine, pp.1-25, 2017. ,
Avis de la commision nationale de l'évaluation des dispositifs médicaux et des technologies de sante : AEQUASYAL. commision nationale de l'évaluation des dispositifs médicaux et des technologies de sante, pp.1-14, 2016. ,
Determinants of poor dental care in patients with schizophrenia: A Historical, Prospective Database Study, J Clin Psychiatry, vol.72, issue.2, pp.140-143, 2011. ,
Dispositions relatives à la protection complémentaire en matière de santé, 2018. ,
The modified dental anxiety scale: UK general public population norms in 2008 with further psychometrics and effects of age, BMC Oral Health, vol.9, issue.20, pp.1-8, 2009. ,
Avis relatif à l'avenant n° 3 à la convention nationale organisant les rapports entre les chirurgiens-dentistes et l'assurance maladie signée le 21 juin, JORF n°0032, SSAS2003111V févr 7, 2018. ,
Un partenariat patients schizophrènes-soignants pour conduire un programme d'éducation en santé orale, Santé Publique, vol.31, issue.4, pp.405-420, 2019. ,
Study protocol: a cluster randomized controlled trial to assess the effectiveness of a therapeutic educational program in oral health for persons with schizophrenia, Int J Ment Health Syst, vol.10, issue.65, pp.1-10, 2016. ,
, Agence nationale de sécurité du médicament et des produits de santé
, Agence nationale de sécurité du médicament et des produits de santé, Agence nationale de sécurité du médicament et des produits de santé. Résumé des caractéristiques du produit : Entonox [Internet, 2017.
, Annexe n°1 : Questionnaire, p.2019
, Annexe n°2 : Réponses de la première question du GOHAI des patients atteints de schizophrénie (SCZ) et de troubles schizoaffectifs (TSA)
, Annexe n°3 : Réponses de la septième question du GOHAI des patients atteints de schizophrénie (SCZ) et de troubles schizoaffectifs (TSA)
, Annexe n°4 : Réponses de la neuvième question du GOHAI des patients atteints de schizophrénie (SCZ) et de troubles schizoaffectifs (TSA)
, Annexe n°5 : Réponses de la douzième question du GOHAI des patients atteints de schizophrénie (SCZ) et de troubles schizoaffectifs (TSA)
, Annexe n°6 : Activité anticholinergique des médicaments
Signature : Vu, la Directrice de l'UFR des Sciences Odontologiques ,